INTRODUCTION
Many neurotransmitters and hormones acting at cell-surface receptors have been shown to stimulate the hydrolysis of a membrane lipid, phosphatidylinositol bisphosphate (PtdInsP2), to give inositol trisphosphate (InsP3) and diacylglycerol. PtdInsP2 in brain has monoester phosphates on the 4-and 5-positions in the myo-inositol ring (Grado & Ballou, 1961) , and therefore inositol 1,4,5-trisphosphate [Ins(1, 4, 5) P3] is the expected InsP3 arising from phospholipase C attack on PtdInsP2. Both diacylglycerol and Ins(1,4,5)P3 have been shown to have second-messenger functions, with diacylglycerol activating protein kinase C and Ins(1,4,5)P3 causing release of Ca2+ from a membrane-associated pool in the endoplasmic reticulum (for reviews, see Nishizuka, 1984; Berridge & Irvine, 1984; Downes and Michell, 1985) . Detection and measurement of InsP3 in agonist-stimulated tissues is therefore of considerable importance to an understanding of the control of cellular physiology through activation of receptors at the cell surface.
In [3H] inositol-prelabelled parotid-gland slices stimulated with cholinergic agonists, most of the InsP3 that accumulates after 10 min exposure to the agonists is inositol 1,3,4-trisphosphate [Ins(1, 3, 4 )P3], with only about 10% of the expected Ins(1,4,5)P3 isomer . Ins(1,4,5)P3 is formed immediately on stimulation and is rapidly degraded after atropine blockade of previously activated muscarinic receptors, in keeping with its proposed second-messenger role. Ins(1,3,4)P3 is only formed after an initial delay of about 5 s and is more slowly metabolized than is the 1,4,5-isomer . Very similar results have been obtained by using [3H] inositol-labelled isolated hepatocytes stimulated with angiotensin (Burgess et al., 1985) . Both the role and the source of Ins(1,3,4)P3 require further investigation.
We have now determined the inositol trisphosphates present in [3H]inositol-labelled parotid glands stimulated with noradrenaline and substance P, which, like cholinergic agonists, stimulate hydrolysis of PtdInsP2 (Weiss et al., 1982) . We have also demonstrated that the likely source of Ins(1,3,4)P3 is not phosphatidylinositol 3,4-bisphosphate, but a novel inositol polyphosphate, inositol 1, 3, 4, 3, 4, 5 )P4], as described in cholinergically stimulated rat brain slices (Batty et al., 1985) .
MATERIALS AND METHODS Materials
Carbachol and atropine were obtained from Sigma. Freon (1,1,2-trichlorotrifluoroethane) and tri-n-octylamine were from BDH. Pre-packed 25 cm-long Partisil 10 SAX columns were supplied by Technicol, Stockport, U.K. AGI and AG50 ion-exchange resins were from Bio-Rad. [3H]Inositol was purchased from New England Nuclear, and [32]P1 was supplied by Amersham. All reagents and chemicals were of the highest grade commercially available.
Tissue incubations
Parotid-gland slices were prepared as described previously , except that the incubation medium contained 20 mM-Hepes (pH 7.4) in place of NaHCO3 and was gassed with°2 rather than 02/CO2 (19: 1) .
For experiments involving labelling with [3H]inositol, 50 1tl portions of washed parotid-gland slices (0.75-1 mg Vol. 238 Abbreviations used: Ins(1,3,4)P,, inositol 1,3,4-trisphosphate; Ins(1,4,5)P,, inositol 1, 4, Ins(1, 3, 4, 5) (carrier-free) . The slices were labelled for 60 min (sufficient to label the monoester phosphates of PtdlnsP and PtdInsP2 close to isotopic equilibrium with the cellular ATP pool; see Weiss et al., 1982) , before addition of agonists as detailed in the legends to Figures.
For analysis of [3H]inositol-labelled water-soluble components, the incubations were terminated by addition of an equal volume of ice-cold 10% (w/v) trichloroacetic acid. Trichloroacetic acid was removed and the samples were prepared for chromatographic procedures exactly as described previously . An alternative method, essentially that of Sharpes & McCarl (1982) , involved terminating the incubations by addition of an equal volume of ice-cold 10% (v/v) HC104. After 10 min on ice, the tissue pellets were centrifuged for 5 min at 2000 rev./min in a Beckman bench-top centrifuge, and 400 u1 'of the supernatant from each sample was transferred to a separate tube containing 100 jul of 10 mM-EDTA (pH 7.0). The samples were neutralized by adding 300 pA of a 1:1 (v/v) mixture of Freon and tri-n-octylamine, followed by vigorous mixing of the separate phases on a vortex mixer. After centrifugation for 1 min at 2000 rev./min, three phases are obtained. The lower phase is Freon plus any tri-n-octylamine that had not reacted; the middle phase is tri-noctylamine perchlorate; and the upper phase is the neutralized sample plus all water-soluble components. A 400,1 portion of the upper phase was removed for subsequent analysis; see below.
Lipid extractions were carried out on tissue incubations that were terminated by addition of 0.94 ml of chloroform/methanol/HCl (40:80: 1, by vol.). Dried lipid extracts were prepared exactly as described previously (Downes & Wusteman, 1983) .
Preparation of standards 32P-labelled Ins(1 ,4,5)P3 was prepared from erythrocyte membranes essentially as described previously (Downes et al., 1982) . Standard samples recovered from AGI columns in ammonium formate/formic acid mixtures were desalted as follows. The column eluate (8 ml) was diluted 5-fold with distilled water and then applied to a column (4 mm internal diameter) containing 0.2 ml of AGI resin (formate form). This column was first eluted with 1.5 ml of 0.5 M-NaOH, which converts most of the resin into the OH-form, yet removes less than 2% of bound inositol phosphates; 90% recovery of InsP3 was then obtained by elution in 4 ml of 2 M-NaOH. NaOH was removed from this sample by passing it down a column containing 9 ml of Bio-Rad AG50 (H+ form; 200-400 (Downes & Wusteman, 1983) as described by Batty et al. (1985) . Neutralized tissue extracts prepared as described above were applied to columns (6mm internal diameter) containing 0.6 ml (wet bed vol.) of Bio-Rad AGI X8 (200-400 mesh; formate form).
[3H]Inositol-labelled compounds were eluted by sequential addition ofammonium formate/formic acid mixtures of increasing ionic strength (see Figure legends for details).
Measurement of radioactive InsP3 isomers, analysis of lipid head groups (see below) and confirmation of the homogeneity of standard compounds were accomplished by anion-exchange h.p.l.c. on a Partisil 10 SAX column eluted with ammonium formate/phosphoric acid gradients as described previously Batty et al., 1985) . Further details are given in the accompanying paper (Hawkins et al., 1986) . Identification of PtdInsP2 head group 32P-labelled parotid-gland phospholipids were deacylated as described by Clarke & Dawson (1981) and the glycerol moieties were then removed by the method of Brown & Stewart (1966) , exactly as described previously . This procedure results in > 90% yield of InsP3 from glycerophosphorylinositol bisphosphate (see Irvine et al., 1985) . 32P-labelled inositol trisphosphates obtained by this procedure were analysed by anion-exchange h.p.l.c. (see above) .
RESULTS
Previous studies demonstrated that prolonged stimulation ofparotid-gland slices with carbachol, noradrenaline or Substance P leads to substantial accumulation of inositol mono-, bis-and tris-phosphates . However, most of the InsP3 that accumulates in carbachol-stimulated slices is Ins(1,3,4)P3 and not Ins(1,4,5)P3. Table 1 shows the results of an experiment in which [3H]inositol-labelled parotid-gland slices were stimulated for 10 min with carbachol, noradrenaline or Substance P, and then the radioactivity associated with each of the InsP3 isomers was determined after they were separated by anion-exchange h.p.l.c. Each of the agonists produced a substantial increase in radioactive Ins(1,3,4)P3, the order of efficacy being carbachol > noradrenaline > Substance P, in keeping with the previous observations that did not separate this isomer from Ins(1,4,5)P3. By contrast, only carbachol produced a significant increase in Ins(1,4,5)P3 after 10 min stimulation.
Determination ofthe head-group structure of parotid-gland PtdInsP2
One possible mechanism whereby agonists could induce accumulation of Ins(1,3,4)P3 is by stimulating phospholipase C attack on a novel lipid, i.e. phosphatidylinositol 3,4-bisphosphate [Ptdlns(3,4)PJ. Since we have developed a chromatographic system that separates Ins(1,3,4)P3 from Ins(1,4,5)P3 and because it was not certain that existing methods for separation of phospholipids would resolve PtdIns(4,5)P2 from the putative Ptdlns(3,4)P2, we elected to derive the phospholipid headgroups from parotid-gland PtdInsP2 and analyse them by anion-exchange h.p.l.c. Any Ins(1,3,4)P3 in the head-group preparation would indicate the existence of Ptdlns(3,4)P2 as its parent lipid.
Parotid-gland slices were heavily labelled with [32P]P1 to generate substantial amounts of [32P]PtdInsP2, so that the occurrence of as little as 1 % of the PtdInsP2 pool as the putative Ptdlns(3,4)P2 could be detected. Fig. 1 shows the h.p.l.c. profile of such a head-group preparation; 98-99% of the radioactivity.in this portion of the chromatograms was eluted as a single symmetrical peak in the position expected for Ins(1,4,5)P3, indicating that the great majority of the parotid gland's PtdInsP2 has the expected PtdIns(4,5)P2 structure. Fig. 1 also indicates the presence of a very low amount of radioactivity in a compound that is eluted from the h.p.l.c. column just before Ins(1,4,5)P3. It amounted to approx. 1% of the Ins(1,4,5)P3 peak and was present in the same proportion in all the chromatograms that we ran for the various incubation conditions described in parotid glands and that any Ptdlns(3,4)P2 must comprise less than 1 %o of the total PtdInsP2 pool.
We also tested the possibility that Ptdlns(3,4)P2 could be formed during agonist stimulation, by analysing the head-group profile of PtdInsP2 after prolonged stimulation with carbachol and-during the recovery phase after atropine blockade of carbachol-stimulated slices. The results are shown in (Taylor et al., 1984) . We speculated that activation of protein kinase C, in the absence of receptor-activated phospholipase C, might cause accumulation of the putative Ptdlns(3,4)P2. However, treatment with tetradecanoylphorbol acetate had no sigiificant effect on steady-state PtdInsP2 content in the parotid gland, and the head-group preparation obtained from slices treated with tetradecanoylphorbol acetate contained no detectable Ins(1,3,4)P3 (Table 2) .
Detection of an inositol tetrkisphosphate in carbacholstimulated parotid glands Batty et al. (1985) have reported the occurrence of Ins(1,3,4,5)P4 in carbachol-stimulated brain slices, and suggested that a similar compound was also present in rat parotid glands. This is confirmed in Fig. 2(a) , which shows the separation of [3H]inositol-labelled acid-soluble compounds from parotid glands stimulated for 20 s with a large dose of carbachol on AGI (formate) columns. This elution profile is very similar to that reported previously , except that the inositol trisphosphate fraction was quantitatively eluted with 0.8 Mammonium formate/0.1 M-formic acid (rather than 1 M-ammonium formate/0.1 M-formic acid as used previously) as described by Batty et al. (1985) . When the eluent concentration was increased to 1.2 M-ammonium formate/0.1 M-formic acid, another peak emerged that was barely present in the samples from control (not stimulated) slices. This final peak was not contaminated with inositol trisphosphates, because it contained no detectable 32P-labelled Ins(1,4,5)P3 standard that was added to the tissue extracts immediately before application to the column. InsP3 isomers are not resolved on these small AGI columns, but Ins(1,4,5)P3 is retained on such columns marginally longer than is Ins(1,3,4)P3 (result not shown).
This quantitative separation of a highly polar inositol phosphate ester from inositol trisphosphates was used to prepare a highly radioactive sample of the novel compound for structure determination. Ten 50,u portions of parotid-gland slices were incubated in Beckman Biovials containing 250 ,1 of incubation medium and 10,uCi of [3H]inositol. The slices were labelled for 90 min at 37°C before addition of carbachol (final concn. 1 mM). The incubations were terminated 20 s later by addition of an equal volume of 10% (v/v) HC104 and the inositol phosphate fraction was obtained as described in the Materials and methods section. The neutralized inositol phosphate fraction was applied to a small AGI (formate) column, and inositol phosphates, up to and including inositol trisphosphates, were eluted in 12 ml of 0.8 M-ammonium formate/0.1 M-formic acid. The novel phosphate ester was then eluted in 8 ml of 1.2 m-ammonium formate/0. 1 M-formic acid, and this sample was desalted as described in the Materials and methods section. This procedure yielded about 80000 d.p.m. of the novel phosphate ester for structural analysis. It contained only a single radioactive peak on anion-exchange h.p.l.c. that was well resolved from [32P]Ins(1,4,5)P3 (Fig. 2b) and had chromatographic properties identical with the Ins(1,3,4,5)P4 identified in brain slices by Batty et al. (1985) .
The procedures that have been used to identify the novel labelled compound in parotid-gland extracts are the same as those described by Batty et al. (1985) . The chromatographic and electrophoretic systems used for identification of polyols, inositol phosphates and free inositol are described by Irvine et al. (1984) and Batty et al. (1985) . It is an inositol tetrakisphosphate because it yielded free inositol after extensive treatmenf with alkaline phosphatase and because it ran with the inositol tetrakisphosphate fraction, obtained by partial dephosphorylation of phytic acid, on paper chromatography (Desjobert & Petek, 1956 ) and ionophoresis in 0.1 Msodium oxalate, pH 1.5 (Seiffert & Agranoff, 1965 . Such studies have revealed that Ins(1,4,5)P3 is formed rapidly (within 5 s) in both carbachol-stimulated rat parotid glands and angiotensinstimulated guinea-pig hepatocytes (Burgess et al., 1985) , and that it is rapidly metabolized when agonist activity is terminated by addition ofa large excess ofa competitive antagonist . The generation of a large Ins(1,3,4)P3 signal is not a phenomenon only of muscarinic-receptor activation, because activation of all three inositol phospholipidcoupled receptors increased Ins(1,3,4)P3 in [3H]inositollabelled parotid-gland slices. However, with the prolonged stimulations with noradrenaline and Substance P shown in Table 1 , there was no significant change in Ins(l,4,5)P3 amounts, although both of these agents raise intracellular Ca2+ concentration in this tissue primarily by releasing Ca2+ from intracellular, non-mitochondrial, stores (Putney, 1977; Poggioli & Putney, 1982) . More detailed studies, employing different times of stimulation (particularly short periods of a few seconds), are required to resolve this apparent paradox.
Secondly, the head-group structure of polyphosphoinositides had, until recently, only been determined for such lipids extracted from brain. Our previous studies have confirmed that the InsP3 obtained from human erythrocyte phospholipids by activation of the erythrocyte membrane phospholipase C also has the Ins(1,4,5)P3 structure. Thus InsP3 obtained by controlled hydrolysis of brain or human erythrocyte PtdInsP2 represents a suitable standard for characterizing chromatographic systems, can be used in studies of the second-messenger role of inositol trisphosphates (see Streb et al., 1983; Berridge & Irvine, 1984) , and can be used to examine the metabolism of Ins(1,4,5)P3 by subcellular fractions (Downes et al., 1982; Storey et al., 1984; Connolly et al., 1985) . The results in the present paper confirm that the only detectable PtdInsP2 in [32P]P1-labelled parotid-gland slices has the Ptdlns(4,5)P2 structure and that a novel phospholipid is very unlikely to be the source of Ins(1,3,4)P3 in this and, presumably, other tissues.
The discovery of Ins(l ,3,4,5)P4 in carbachol-stimulated brain slices and its conversion into Ins(1,3,4)P3 by human erythrocyte membranes led Batty et al. (1985) to propose that InsP4 is likely to be the precursor for Ins(1,3,4)P3 in brain. They also noted the occurrence of a compound with similar properties to InsP4 in carbachol-stimulated parotid glands. We have extended their initial observations in confirming that parotid glands also contain Ins(1,3,4,5)P4. Further, more detailed results, describing the kinetics ofInsP4 formation in stimulated glands, its metabolism by parotid-gland homogenates and the source of its production are presented in the accompanying paper (Hawkins et al., 1986) .
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